A systematic review of the early dialogue frameworks used within health technology assessment and their actual adoption from HTA agencies.

Autor:	Ibargoyen-Roteta N; Basque Office for HTA (Osteba)/Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain., Galnares-Cordero L; Basque Office for HTA (Osteba)/Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain., Benguria-Arrate G; Basque Office for HTA (Osteba)/Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain., Chacón-Acevedo KR; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., Gutiérrez-Sepulveda MP; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., Low-Padilla E; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., De La Hoz-Siegler IH; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., Guevara-Pérez CI; Translational Research Group, Global Institute for Clinical Excellence, Keralty SAS, Bogotá, Colombia., Del Pozo-Pérez Á; Biokeralty Research Institute AIE, Miñano, Spain., Suárez M; Biokeralty Research Institute AIE, Miñano, Spain., Dauben HP; dkHealth Partners, Cologne, Germany., Otte M; International HealthTechScan (i-HTS), Cologne, Germany., Gutiérrez-Ibarluzea I; Basque Office for HTA (Osteba)/Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain.; Basque Foundation for Health Innovation and Research (BIOEF), Barakaldo, Spain.
Jazyk:	angličtina
Zdroj:	Frontiers in public health [Front Public Health] 2022 Oct 06; Vol. 10, pp. 942230. Date of Electronic Publication: 2022 Oct 06 (Print Publication: 2022).
DOI:	10.3389/fpubh.2022.942230
Abstrakt:	Introduction: Early advice in the process of developing health technologies allows manufacturers to plan their production and transfer to health care systems more accurately. This review aims to describe frameworks used within HTA and their current use by HTA Agencies. Material and Methods: We carried out a systematic literature review in Pubmed, Embase, Scopus, and WoS, including all references published in Spanish and English. This was last updated in March 2022. We extracted all available information regarding the organizations involved, services offered, types of technology, collaborators involved, fees, output and impact. Websites of several HTA organizations and Google were also searched in order to update and complete the information obtained from this generic search. Results: Five-hundred and forty one articles were identified and screened, of which 26 met the eligibility criteria and were selected. Seven of them were non-systematic reviews that described two or more HTA organizations. Ten studies were focused on the advice offered by individual organizations, and eight described the EMA and EUnetHTA parallel or joint advice. We found variations in the technology assessed, services offered, stage of development and costs for advisory services. Conclusions: Early and scientific advice would help manufacturers focus their product development on what is needed for the management of specific diseases. Most of the examples or services found refer to drugs as well as to some medical devices and diagnostics. A common definition of the type of advice that could be offered for different health technologies by HTA bodies to ascertain health care systems and manufacturers' needs, in addition to the timeline in which that advice needs to be given, would help HTA bodies provide the right support at the right time. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020219401, PROSPERO CRD42020219401. Competing Interests: Authors KC-A, MG-S, EL-P, ID, CG-P, AP-P, and MS were employed by Keralty SAS. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2022 Ibargoyen-Roteta, Galnares-Cordero, Benguria-Arrate, Chacón-Acevedo, Gutiérrez-Sepulveda, Low-Padilla, De La Hoz-Siegler, Guevara-Pérez, Pozo-Pérez, Suárez, Dauben, Otte and Gutiérrez-Ibarluzea.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu